Genor Biopharma Announces Acceptance of New Drug Application for Geptanolimab and Appointment of Mr. CHEN Wende as Chief Operation Officer
HONG KONG, July 21, 2020 – (ACN Newswire) – Genor Biopharma Co. Inc, a pre-commercial stage biopharmaceutical company focused on
Read More